Subscribe To
ORGO / Organogenesis Holdings Inc. (ORGO) CEO Gary Gillheeney on Q3 2021 Results - Earnings Call Transcript
Content Topics
Organogenesis
Holdings
Inc
ORGO
Gary
Gillheeney
2021
orgo
Results
Earnings
Transcript
Stock
ORGO News
By The Motley Fool
September 28, 2023
Why Shares of Organogenesis Holdings Are Up Thursday
Organogenesis focuses on advanced wound products. The company's second-quarter revenue and net income were down year over year. more_horizontal
By The Motley Fool
May 24, 2023
Why Shares of Organogenesis Climbed Wednesday
An analyst updated Organogenesis' price target. Competitor Integra LifeSciences said Tuesday it was recalling a product. more_horizontal
By The Motley Fool
May 11, 2023
Why Shares of Organogenesis Holdings Jumped Thursday
Organogenesis said it expects sales to rise between 1% and 3% this year. The company said revenue rose by 10% year over year in the first quarter. more_horizontal
By Seeking Alpha
May 10, 2023
Organogenesis Holdings Inc. (ORGO) Q1 2023 Earnings Call Transcript
Organogenesis Holdings Inc. (NASDAQ:ORGO ) Q1 2023 Earnings Conference Call May 10, 2023 5:00 PM ET Company Participants Gary Gillheeney - President a more_horizontal
By GlobeNewsWire
April 10, 2023
Organogenesis Holdings Inc. to Report First Quarter of Fiscal Year 2023 Financial Results on May 10, 2023
CANTON, Mass., April 10, 2023 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the d more_horizontal
By Seeking Alpha
March 1, 2023
Organogenesis Holdings Inc. (ORGO) Q4 2022 Earnings Call Transcript
Organogenesis Holdings Inc. (NASDAQ:ORGO ) Q4 2022 Earnings Conference Call March 1, 2023 5:00 PM ET Company Participants Gary Gillheeney - President more_horizontal
By Seeking Alpha
November 9, 2022
Organogenesis Holdings Inc. (ORGO) Q3 2022 Earnings Call Transcript
Organogenesis Holdings Inc. (NASDAQ:ORGO ) Q3 2022 Earnings Conference Call November 9, 2022 5:00 PM ET Corporate Participants Gary Gillheeney - Presi more_horizontal
By The Motley Fool
August 10, 2022
Why Organogenesis Stock Is Tumbling Today
It didn't make as much money in the second quarter as investors were hoping. more_horizontal